<DOC>
	<DOCNO>NCT03041324</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability effect leukocyte plasma Iduronate 2-Sulfatase ( IDS ) enzyme activity ascend dos SB-913 . SB-913 intravenously deliver Zinc Finger Nuclease ( ZFN ) Therapeutic genome editing . It insert correct copy IDS gene Albumin locus hepatocytes goal lifelong therapeutic production IDS enzyme .</brief_summary>
	<brief_title>Ascending Dose Study Genome Editing Zinc Finger Nuclease ( ZFN ) Therapeutic SB-913 Subjects With MPS II</brief_title>
	<detailed_description>The objective study provide long term expression IDS improve current clinical outcome enzyme replacement therapy ( ERT ) subject MPS II , recessive lysosomal storage disorder result mutation gene encode IDS . SB-913 therapeutic ZFN-mediated genome edit deliver adeno-associated virus ( AAV ) -derived vector . SB-913 intended function placement corrective copy IDS transgene genome subject 's hepatocytes , control highly express endogenous albumin locus , expect provide permanent , liver-specific expression Iduronate 2-Sulfatase lifetime MPS II patient .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis II</mesh_term>
	<criteria>Male &gt; 18 year age Clinical diagnosis attenuate MPS II ( base evidence hepatosplenomegaly , dysostosis multiplex Xray , valvular heart disease , obstructive airway disease ) Known unresponsive ERT Neutralizing antibody AAV 2/6 Serious intercurrent illness clinically significant organic disease ( unless secondary MPS II ) Receiving antiviral therapy hepatitis B C , active hepatitis B hepatitis C HIV 1/2 Lack tolerance idursulfase treatment significant IARs occurrence anaphylaxis Markers hepatic dysfunction Creatinine ≥ 1.5 mg/dL Contraindication use corticosteroid immunosuppression Current treatment systemic ( IV oral ) immunomodulatory agent steroid use ( topical treatment allow ) Participation prior investigational drug medical device study within previous 3 month Prior treatment gene therapy product Elevated abnormal circulate αfetoprotein ( AFP )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>